E. Gary Cook

Envirokare Tech, Inc. designs, develops and manufactures, utilizes proprietary thermoplastic composite technologies, including Thermo Plastic Flowforming for TPF(TM). The end-use products of this process are fabricated using other materials, including wood, metal, concrete or reinforced thermoset resins-fiber-glass. The Group also focuses licenses proprietary process technology to manufacturers and converters. The company was incorporated on June 15, 1998 and is headquartered in New York, NY.

EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN.

United Way of Northeast Florida, Inc. is a not-for-profit organization that works to change by focusing on the building blocks for a good life with volunteers, community organizations and leaders, The company was founded in 1924 and is headquartered in Jacksonville, FL.

Ethyl Corp. provides blending and supply solutions. The firm supplies gasoline performance additives and diesel cetane improvers. It also offers terminal, storage, and trans loading services. The company was founded on February 15, 1887 and is headquartered in Richmond, VA.

Part of InEnTec, Inc., InEnTec Chemical LLC develops renewable waste management technologies. The private company is based in Fleming Island, FL. E. Gary Cook has been the CEO of the company since 2006. InEnTec Chemical was acquired by InEnTec, Inc. on April 03, 2012.

Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.